Literature DB >> 21187359

Incidence and risk factors associated with lost to follow-up in a Belgian cohort of HIV-infected patients treated with highly active antiretroviral therapy.

T Schepens1, S Morreel, E Florence, O Koole, R Colebunders.   

Abstract

Being lost to follow-up (LTFU) is a major problem in caring for persons with HIV infection. We describe the proportions and characteristics of LTFU in a Belgian outpatient HIV clinic. All patients treated with highly active antiretroviral therapy (HAART) who attended at least two consultations were included. Patients not returning within the following year were considered LTFU. Multivariate analysis using logistic regression was performed. The LTFU rate was 5.5% on average and remained stable over the years. Patients LTFU were more often intravenous drug users (odds ratio [OR] = 3.48), not covered by health insurance (OR = 6.69), living outside the province (OR = 1.49) and treated with a complex initial HAART regimen (OR = 5.80). Increased age was also associated with a higher risk of LTFU. Patients at risk for LTFU after starting HAART should be the targeted for reinforced counselling and HIV treatment centres should establish systems to trace patients LTFU.

Entities:  

Mesh:

Year:  2010        PMID: 21187359     DOI: 10.1258/ijsa.2010.010303

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  7 in total

1.  Comparing different measures of retention in outpatient HIV care.

Authors:  Baligh R Yehia; John A Fleishman; Joshua P Metlay; P Todd Korthuis; Allison L Agwu; Stephen A Berry; Richard D Moore; Kelly A Gebo
Journal:  AIDS       Date:  2012-06-01       Impact factor: 4.177

2.  Reengagement in Care After a Gap in HIV Care Among a Population of Privately Insured Persons with HIV in the United States.

Authors:  Kathy K Byrd; Melissa Furtado; Tim Bush; Lytt Gardner
Journal:  AIDS Patient Care STDS       Date:  2016-11       Impact factor: 5.078

3.  Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users.

Authors:  Ryan P Westergaard; Timothy Hess; Jacquie Astemborski; Shruti H Mehta; Gregory D Kirk
Journal:  AIDS       Date:  2013-10-23       Impact factor: 4.177

4.  Evaluating patterns in retention, continuation, gaps, and re-engagement in HIV care in a Medicaid-insured population, 2006-2012, United States.

Authors:  Kathy K Byrd; Melissa Furtado; Tim Bush; Lytt Gardner
Journal:  AIDS Care       Date:  2015

5.  Loss to follow-up in anti-HCV-positive patients in a Brazilian regional outpatient clinic.

Authors:  L C Mendes; S M Ralla; A G Vigani
Journal:  Braz J Med Biol Res       Date:  2016-08-25       Impact factor: 2.590

6.  Incidence rate, predictors and outcomes of interruption of HIV care: nationwide results from the Belgian HIV cohort.

Authors:  D Van Beckhoven; E Florence; S De Wit; C Wyndham-Thomas; A Sasse; H Van Oyen; J Macq
Journal:  HIV Med       Date:  2020-07-05       Impact factor: 3.180

7.  The effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial.

Authors:  David H Gustafson; Gina Landucci; Fiona McTavish; Rachel Kornfield; Roberta A Johnson; Marie-Louise Mares; Ryan P Westergaard; Andrew Quanbeck; Esra Alagoz; Klaren Pe-Romashko; Chantelle Thomas; Dhavan Shah
Journal:  Trials       Date:  2016-12-12       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.